The risk control underlying co-developed by MerQube and J.P. Morgan has had a strong start of the year.

Products sold in the US market linked to the three MerQube Vol Advantage indices have called the attention of investors – they were all issued by J.P. Morgan, an affiliate of which holds a 10% equity interest in MerQube, the index sponsor and calculation agent. Year-to-date (YTD), the US bank has issued 61 SEC-registered structured notes linked to the MerQube US Tech+ Vol Advantage Index , which amounted to US$80m principal amount, making up almost half of the total sales linked to the in

Continue reading and get unlimited access for 7 days with a free trial of SRP.

Get a free trial

Already a subscriber? Login